An ankle sprain is one of the most common injuries. Usually the pain and swelling settle with rest and treatment, but for some people discomfort lingers. Ongoing ankle pain can sometimes be linked to wear within the joint. This article looks at persistent ankle pain and how a non-surgical option — the ChondroFiller injection — may fit in, with realistic expectations throughout.

When Ankle Pain Lingers

While a sprain mainly involves the ligaments, persistent pain can have other causes within the joint, including wear of the ankle's cartilage over time. The ankle is a highly congruent joint that bears considerable load with every step, and its cartilage has limited capacity for spontaneous repair. Ongoing ache, swelling or a feeling of instability that does not settle is worth assessing properly, often with imaging such as an MRI, so the right approach can be chosen.

What Is the ChondroFiller Injection?

ChondroFiller is a Class III CE-marked medical device: an acellular type I collagen hydrogel scaffold made by Meidrix Biomedicals in Germany and used in the UK under prescription. When delivered into a joint, the scaffold self-gels within a few minutes, forming a porous three-dimensional matrix that can fill worn areas of cartilage. It is acellular — meaning it contains no donor cells — and works by providing a structural environment that recruits the patient's own progenitor cells from the surrounding tissue, supporting biological repair.

As a non-surgical injection, ChondroFiller is delivered as an ultrasound-guided outpatient procedure using a fine needle and no incision. There is no theatre, no general anaesthetic, and no arthroscopic surgery involved. It is best understood as a supportive, joint-preserving treatment rather than a guaranteed repair. It is not a cure for arthritis, and whether it helps — and for how long — varies from person to person. The CE marking and the published outcome data belong to ChondroFiller as a device; it is distinct from the Liquid Cartilage procedure, which is Professor Paul Lee's keyhole surgical protocol and a separate treatment pathway suited to larger or more complex defects.

What to Expect

Treatment begins with a thorough assessment, including imaging and clinical examination. ChondroFiller is then given as an ultrasound-guided injection into the joint; the collagen solution is introduced under image guidance to ensure accurate placement over the affected area of cartilage. Because it is a non-surgical injection, there is no operation and no lengthy surgical recovery. Most people return to normal daily activities promptly and ease back into higher-impact activity as advised by their clinician.

Is It Right for You?

The ChondroFiller injection may suit people with persistent ankle pain linked to joint wear who want a non-surgical option and have realistic expectations. It will not be right for everyone — suitability depends on the joint, the degree of wear, overall health and individual goals, and benefits cannot be guaranteed. A thorough assessment is essential before any treatment decision is made.

At the London Cartilage Clinic, Professor Paul Lee and the team provide a comprehensive assessment and help you decide whether the ChondroFiller injection — or another option, including the Liquid Cartilage surgical procedure for cases requiring a keyhole approach — best fits your needs.

Conclusion

Ongoing ankle pain after a sprain should not be ignored. A non-surgical collagen injection such as ChondroFiller may help support the joint and ease symptoms for some people. For personalised advice, always consult a qualified healthcare professional.

References

Corain M, Zanotti F, Giardini M, Gasperotti L, Invernizzi E, Biasi V, Lavagnolo U. The use of an acellular collagen matrix ChondroFiller Liquid for trapeziometacarpal osteoarthritis. Cartilage. 2023.